ConsumerAffairs

Novo Nordisk launches its Wegovy Pill weight-loss drug to the US market, GoodRx discounts it

Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments that have reshaped the obesity
KADN News 15

Covering Your Health: FDA approves oral version of Wegovy for weight loss

Federal health officials have released new dietary guidelines aimed at encouraging Americans to avoid processed foods and added sugar. Meanwhile, the FDA has approved the first-ever weight

Best Peptides for Weight Loss 2026: Oral Wegovy Launch Expands GLP-1 Format Options as Telehealth Platforms Compare FDA-Approved vs Compounded Semaglutide Access

Following Oral Wegovy Introduction, Consumer Analysis Examines Injectable vs Oral Semaglutide Pricing, Compounded Tirzepatide Access Through Direct Meds, and Three-Entity Telehealth Platform StructureHOUSTON,
Health on MSN

Zepbound vs Ozempic: Which Works Better for Weight Loss and How They Compare

If you are considering both Ozempic and Zepbound for weight loss, it can be helpful to compare the two side by side before making a decision.
AOL

8 FDA-approved weight loss drugs: What are they & what are their side effects?

Most weight loss drugs are FDA-approved for people with obesity or overweight with a weight-related health condition. A healthcare provider can help you find the best weight loss medication for you. The Food and Drug Administration (FDA) has approved some ...

CMS’ BALANCE Model Aims To Resolve Medicare Coverage Of Weight-Loss Drugs

CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while tackling coverage & adherence challenges.
Feedback